News und Media
Aktuelle News und Presseberichte
Europäische Kommission erteilt Marktzulassung für Vueway® (Gadopiclenol)
Die Europäische Kommission hat am 7. Dezember 2023 die Marktzulassung für das neue MR-Kontrastmittel Vueway® (Gadopiclenol) von Bracco Imaging S.p.A. erteilt.
Mehr Transparenz, mehr Service
Die neue Service-Website www.gesundheitspolitik-bracco.de informiert über Wissenswertes aus der bildgebenden Diagnostik.
Vueway® (Gadopiclenol) erhält positive CHMP-Beurteilung
Der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittelagentur (EMA) hat die Zulassung des makrozyklischen, hochrelaxierenden Vueway® (Gadopiclenol) bei Erwachsenen und pädiatrischen Patienten ab 2 Jahren empfohlen1.
Bracco gewinnt EcoVadis Goldmedaille
Bracco erhält im Rahmen der diesjährigen Nachhaltigkeitsprüfung die EcoVadis-Auszeichnung in Gold für herausragende Leistungen in den Bereichen Umweltschutz,
Ethik, Arbeits- und Menschenrechte sowie nachhaltige Beschaffung.
Stell Dir vor, es ist Ausschreibung und keiner macht mit
Die Firma Bracco Imaging Deutschland GmbH hat sich erstmals in der Firmengeschichte – wenn auch mit großem Bedauern – gegen eine Teilnahme an der kürzlich veröffentlichten Kontrastmittel-Exklusivausschreibung in den KV-Regionen Schleswig-Holstein, Rheinland-Pfalz und Saarland entschieden.
Join us celebrating our new website
We are thrilled to open the doors of our “digital house” created by our people and inhabited by our stories
Drivers and barriers: Innovation in healthcare
Alberto Spinazzi, Bracco Chief Medical and Regulatory Officer, answers some of these questions by illustrating future trends and the importance of prevention for human health.
Bracco’s “The Beauty of Imaging”
The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine
Talking Images podcast: The sustainable way – voices of action
Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?
FDA approves Gadopiclenol injection for the U.S. market
Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.
BIPSO further strengthens environmental protection
BIPSO sets the course for sterile contrast media production according to the latest environmental standards.
Bracco’s digital historical archive goes online
The astounding Bracco story unfolds across archives that have been thematically divided into five sections: Family, Company, Innovation, Sustainability, and Culture.
Gadopiclenol: another milestone achieved
Bracco Imaging and Guerbet have a worldwide collaboration on Gadopiclenol, an investigational macrocyclic gadolinium-based contrast agent (GBCA).
The Bracco Fellowships are back
95 grants to celebrate Bracco’s 95th Anniversary
The US shortage crisis: Bracco Imaging’s CEO statement on New York Times
The US shortage crisis: Bracco Imaging’s CEO statement on New York Times
Cathena has ended: a customised nanomedicine project
A new customised nanomedicine project to fight cancer, a new therapy that includes pre-treating
First Ukrainian family is welcomed in housing provided by Bracco near the Cesano plant
They have left the war in Ukraine behind and have been welcomed in Italy by the Bracco Group in collaboration with the Town of Cesano and the local community.
Bracco Foundation meets Shaharzad Akbar, not to forget the Afghan women
Shaharzad Akbar arrived from Rome where she had provided testimony during a meeting of Italy’s Chamber of Deputies and Senate Joint Committee on Foreign Affairs.
The world cannot grow without gender equality
Some of the goals in a Policy Paper drafted by the B20 Special Initiative on Women’s Empowerment.
Diana Bracco and Gianvito Vilé, winner of the Felder Award, appear at Trieste Next Festival
Trieste Next Festival: Diana Bracco and Gianvito Vilé talk about scientific research and the brain drain.
The Bracco Foundation: ten years in the name of culture, science and social engagement
The Bracco Foundation: ten years in the name of culture, science and social engagement.
Presse-Kontakt
If you are a journalist and you need more information about the Bracco Group.
Bracco Group
Media Relations
Tel. +39 (02) 21772279
Email: [email protected]
Bracco Imaging S.p.A.
Media Relations
Via Egidio Folli 50, 20134 - Milan, Italy
Schreiben Sie uns
Füllen Sie einfach das Kontaktformular vollständig aus - wir setzen uns anschließend mit Ihnen in Verbindung.